GRRMY (Gerresheimer AG) PEG Ratio: N/A (As of Jul. 09, 2026)


GRRMY Gerresheimer AG GRRMY
60 GF Score
Price $8.50
GF Value $28.75
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Gerresheimer AG PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Gerresheimer AG's PE Ratio without NRI is 0.00. Gerresheimer AG's 5-Year EBITDA growth rate is -0.30%. Therefore, Gerresheimer AG's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Gerresheimer AG's PEG Ratio or its related term are showing as below:


During the past 13 years, Gerresheimer AG's highest PEG Ratio was 2634.00. The lowest was 0.96. And the median was 5.92.


GRRMY's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.89
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Gerresheimer AG  (OTCPK:GRRMY) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Gerresheimer AG PEG Ratio Related Terms


Gerresheimer AG PEG Ratio Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG PEG Ratio Chart

Gerresheimer AG Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 113.60 0.00 23.13 5.17 0.00

Gerresheimer AG Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.17 8.98 10.36 0.00 0.00

GRRMY vs ISRG, BDX, MDLN: PEG Ratio Comparison

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's PEG Ratio falls into.


GRRMY
60GF Score
Gerresheimer AG GRRMY
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Gerresheimer AG's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/-0.30
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Gerresheimer AG (GRRMY) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of $8.50 is trading 70.4% below its estimated GF Value™ of $28.75. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for GRRMY:

  • PEG Ratio: N/A
  • GF Value™: $28.75 vs. price of $8.50 (70.4% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the GRRMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
60GF Score

Get the complete analysis for GRRMY

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.50
Price
$28.75
GF Value